Global Drug Eluting Balloon for Coronary Artery Disease Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 75
Published Date: 05 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Drug Eluting Balloon for Coronary Artery Disease market size was valued at USD 454.1 million in 2023 and is forecast to a readjusted size of USD 1216 million by 2030 with a CAGR of 15.1% during review period.
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
The Coronary Drug-Coated Balloon market is driven by the need for improved treatment options for coronary artery disease (CAD). These specialized balloons are designed to deliver drugs directly to the site of arterial blockages during angioplasty, preventing restenosis and promoting vessel healing. The rise in CAD cases and the demand for minimally invasive interventions contribute to market growth as patients and cardiologists seek solutions that reduce the need for repeat procedures. Moreover, advancements in drug formulation and balloon technology, including controlled drug release and enhanced drug adherence, align with better patient outcomes. However, the market also faces challenges, including addressing the potential for adverse reactions to the drug coating and ensuring precise drug delivery to the targeted area. Additionally, navigating regulatory approvals and conducting long-term efficacy studies can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective drug-coated balloon solutions, collaborate with interventional cardiologists for insights, and address the challenges to meet the increasing demand for advanced CAD treatment options.
The Global Info Research report includes an overview of the development of the Drug Eluting Balloon for Coronary Artery Disease industry chain, the market status of Hospitals (Paclitaxel Coated, Other Coated), ASCs (Paclitaxel Coated, Other Coated), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drug Eluting Balloon for Coronary Artery Disease.
Regionally, the report analyzes the Drug Eluting Balloon for Coronary Artery Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drug Eluting Balloon for Coronary Artery Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Drug Eluting Balloon for Coronary Artery Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drug Eluting Balloon for Coronary Artery Disease industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Paclitaxel Coated, Other Coated).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drug Eluting Balloon for Coronary Artery Disease market.
Regional Analysis: The report involves examining the Drug Eluting Balloon for Coronary Artery Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drug Eluting Balloon for Coronary Artery Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Drug Eluting Balloon for Coronary Artery Disease:
Company Analysis: Report covers individual Drug Eluting Balloon for Coronary Artery Disease manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drug Eluting Balloon for Coronary Artery Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, ASCs).
Technology Analysis: Report covers specific technologies relevant to Drug Eluting Balloon for Coronary Artery Disease. It assesses the current state, advancements, and potential future developments in Drug Eluting Balloon for Coronary Artery Disease areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drug Eluting Balloon for Coronary Artery Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Drug Eluting Balloon for Coronary Artery Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Paclitaxel Coated
Other Coated
Market segment by Application
Hospitals
ASCs
Catheterization Laboratory
Major players covered
B. Braun
Yinyi
Eurocor
Biotronic
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Eluting Balloon for Coronary Artery Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Drug Eluting Balloon for Coronary Artery Disease, with price, sales, revenue and global market share of Drug Eluting Balloon for Coronary Artery Disease from 2019 to 2024.
Chapter 3, the Drug Eluting Balloon for Coronary Artery Disease competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Eluting Balloon for Coronary Artery Disease breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Drug Eluting Balloon for Coronary Artery Disease market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Drug Eluting Balloon for Coronary Artery Disease.
Chapter 14 and 15, to describe Drug Eluting Balloon for Coronary Artery Disease sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Drug Eluting Balloon for Coronary Artery Disease
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Paclitaxel Coated
1.3.3 Other Coated
1.4 Market Analysis by Application
1.4.1 Overview: Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 ASCs
1.4.4 Catheterization Laboratory
1.5 Global Drug Eluting Balloon for Coronary Artery Disease Market Size & Forecast
1.5.1 Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity (2019-2030)
1.5.3 Global Drug Eluting Balloon for Coronary Artery Disease Average Price (2019-2030)
2.1 B. Braun
2.1.1 B. Braun Details
2.1.2 B. Braun Major Business
2.1.3 B. Braun Drug Eluting Balloon for Coronary Artery Disease Product and Services
2.1.4 B. Braun Drug Eluting Balloon for Coronary Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 B. Braun Recent Developments/Updates
2.2 Yinyi
2.2.1 Yinyi Details
2.2.2 Yinyi Major Business
2.2.3 Yinyi Drug Eluting Balloon for Coronary Artery Disease Product and Services
2.2.4 Yinyi Drug Eluting Balloon for Coronary Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Yinyi Recent Developments/Updates
2.3 Eurocor
2.3.1 Eurocor Details
2.3.2 Eurocor Major Business
2.3.3 Eurocor Drug Eluting Balloon for Coronary Artery Disease Product and Services
2.3.4 Eurocor Drug Eluting Balloon for Coronary Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Eurocor Recent Developments/Updates
2.4 Biotronic
2.4.1 Biotronic Details
2.4.2 Biotronic Major Business
2.4.3 Biotronic Drug Eluting Balloon for Coronary Artery Disease Product and Services
2.4.4 Biotronic Drug Eluting Balloon for Coronary Artery Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Biotronic Recent Developments/Updates
3.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Manufacturer (2019-2024)
3.2 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Manufacturer (2019-2024)
3.3 Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Drug Eluting Balloon for Coronary Artery Disease by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Drug Eluting Balloon for Coronary Artery Disease Manufacturer Market Share in 2023
3.4.2 Top 6 Drug Eluting Balloon for Coronary Artery Disease Manufacturer Market Share in 2023
3.5 Drug Eluting Balloon for Coronary Artery Disease Market: Overall Company Footprint Analysis
3.5.1 Drug Eluting Balloon for Coronary Artery Disease Market: Region Footprint
3.5.2 Drug Eluting Balloon for Coronary Artery Disease Market: Company Product Type Footprint
3.5.3 Drug Eluting Balloon for Coronary Artery Disease Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Drug Eluting Balloon for Coronary Artery Disease Market Size by Region
4.1.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2030)
4.1.2 Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Region (2019-2030)
4.1.3 Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Region (2019-2030)
4.2 North America Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030)
4.3 Europe Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030)
4.4 Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030)
4.5 South America Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030)
4.6 Middle East and Africa Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030)
5.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
5.2 Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Type (2019-2030)
5.3 Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Type (2019-2030)
6.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
6.2 Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Application (2019-2030)
6.3 Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Application (2019-2030)
7.1 North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
7.2 North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
7.3 North America Drug Eluting Balloon for Coronary Artery Disease Market Size by Country
7.3.1 North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2030)
7.3.2 North America Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
8.2 Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
8.3 Europe Drug Eluting Balloon for Coronary Artery Disease Market Size by Country
8.3.1 Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2030)
8.3.2 Europe Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Market Size by Region
9.3.1 Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
10.2 South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
10.3 South America Drug Eluting Balloon for Coronary Artery Disease Market Size by Country
10.3.1 South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2030)
10.3.2 South America Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Market Size by Country
11.3.1 Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Drug Eluting Balloon for Coronary Artery Disease Market Drivers
12.2 Drug Eluting Balloon for Coronary Artery Disease Market Restraints
12.3 Drug Eluting Balloon for Coronary Artery Disease Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Drug Eluting Balloon for Coronary Artery Disease and Key Manufacturers
13.2 Manufacturing Costs Percentage of Drug Eluting Balloon for Coronary Artery Disease
13.3 Drug Eluting Balloon for Coronary Artery Disease Production Process
13.4 Drug Eluting Balloon for Coronary Artery Disease Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Drug Eluting Balloon for Coronary Artery Disease Typical Distributors
14.3 Drug Eluting Balloon for Coronary Artery Disease Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. B. Braun Basic Information, Manufacturing Base and Competitors
Table 4. B. Braun Major Business
Table 5. B. Braun Drug Eluting Balloon for Coronary Artery Disease Product and Services
Table 6. B. Braun Drug Eluting Balloon for Coronary Artery Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. B. Braun Recent Developments/Updates
Table 8. Yinyi Basic Information, Manufacturing Base and Competitors
Table 9. Yinyi Major Business
Table 10. Yinyi Drug Eluting Balloon for Coronary Artery Disease Product and Services
Table 11. Yinyi Drug Eluting Balloon for Coronary Artery Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Yinyi Recent Developments/Updates
Table 13. Eurocor Basic Information, Manufacturing Base and Competitors
Table 14. Eurocor Major Business
Table 15. Eurocor Drug Eluting Balloon for Coronary Artery Disease Product and Services
Table 16. Eurocor Drug Eluting Balloon for Coronary Artery Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Eurocor Recent Developments/Updates
Table 18. Biotronic Basic Information, Manufacturing Base and Competitors
Table 19. Biotronic Major Business
Table 20. Biotronic Drug Eluting Balloon for Coronary Artery Disease Product and Services
Table 21. Biotronic Drug Eluting Balloon for Coronary Artery Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Biotronic Recent Developments/Updates
Table 23. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 24. Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Manufacturer (2019-2024) & (USD Million)
Table 25. Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 26. Market Position of Manufacturers in Drug Eluting Balloon for Coronary Artery Disease, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 27. Head Office and Drug Eluting Balloon for Coronary Artery Disease Production Site of Key Manufacturer
Table 28. Drug Eluting Balloon for Coronary Artery Disease Market: Company Product Type Footprint
Table 29. Drug Eluting Balloon for Coronary Artery Disease Market: Company Product Application Footprint
Table 30. Drug Eluting Balloon for Coronary Artery Disease New Market Entrants and Barriers to Market Entry
Table 31. Drug Eluting Balloon for Coronary Artery Disease Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2024) & (K Units)
Table 33. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Region (2025-2030) & (K Units)
Table 34. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 35. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 36. Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Region (2019-2024) & (US$/Unit)
Table 37. Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Region (2025-2030) & (US$/Unit)
Table 38. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 39. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 40. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 41. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 42. Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Type (2019-2024) & (US$/Unit)
Table 43. Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Type (2025-2030) & (US$/Unit)
Table 44. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 45. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 46. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 47. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 48. Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Application (2019-2024) & (US$/Unit)
Table 49. Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Application (2025-2030) & (US$/Unit)
Table 50. North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 51. North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 52. North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 53. North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 54. North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2024) & (K Units)
Table 55. North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2025-2030) & (K Units)
Table 56. North America Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 57. North America Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 58. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 59. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 60. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 61. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 62. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2024) & (K Units)
Table 63. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2025-2030) & (K Units)
Table 64. Europe Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 65. Europe Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 66. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 67. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 68. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 69. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 70. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2024) & (K Units)
Table 71. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Region (2025-2030) & (K Units)
Table 72. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 73. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 74. South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 75. South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 76. South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 77. South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 78. South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2019-2024) & (K Units)
Table 79. South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Country (2025-2030) & (K Units)
Table 80. South America Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 81. South America Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 82. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 83. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 84. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 85. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 86. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Region (2019-2024) & (K Units)
Table 87. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity by Region (2025-2030) & (K Units)
Table 88. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 89. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 90. Drug Eluting Balloon for Coronary Artery Disease Raw Material
Table 91. Key Manufacturers of Drug Eluting Balloon for Coronary Artery Disease Raw Materials
Table 92. Drug Eluting Balloon for Coronary Artery Disease Typical Distributors
Table 93. Drug Eluting Balloon for Coronary Artery Disease Typical Customers
List of Figures
Figure 1. Drug Eluting Balloon for Coronary Artery Disease Picture
Figure 2. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Type in 2023
Figure 4. Paclitaxel Coated Examples
Figure 5. Other Coated Examples
Figure 6. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Application in 2023
Figure 8. Hospitals Examples
Figure 9. ASCs Examples
Figure 10. Catheterization Laboratory Examples
Figure 11. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Drug Eluting Balloon for Coronary Artery Disease Average Price (2019-2030) & (US$/Unit)
Figure 15. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Drug Eluting Balloon for Coronary Artery Disease by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Drug Eluting Balloon for Coronary Artery Disease Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Drug Eluting Balloon for Coronary Artery Disease Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Type (2019-2030) & (US$/Unit)
Figure 30. Global Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Application (2019-2030) & (US$/Unit)
Figure 33. North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Region (2019-2030)
Figure 53. China Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Drug Eluting Balloon for Coronary Artery Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Drug Eluting Balloon for Coronary Artery Disease Market Drivers
Figure 74. Drug Eluting Balloon for Coronary Artery Disease Market Restraints
Figure 75. Drug Eluting Balloon for Coronary Artery Disease Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Drug Eluting Balloon for Coronary Artery Disease in 2023
Figure 78. Manufacturing Process Analysis of Drug Eluting Balloon for Coronary Artery Disease
Figure 79. Drug Eluting Balloon for Coronary Artery Disease Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
B. Braun Yinyi Eurocor Biotronic
Related Reports
09 Sep 2022
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
